RECIPIENT-TO-DONOR ANTI-CMV IGG RATIO AS A PREDICTOR OF CMV REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE-CONTROL STUDY. Mediterr J Hematol Infect Dis 2026, 18 (1), e2026078. https://doi.org/10.4084/MJHID.2026.078.